Physiologic Definition of Bronchopulmonary Dysplasia
PhysiologicDef
43 other identifiers
observational
410
1 country
21
Brief Summary
This observational study was conducted to design and test a physiologic definition for bronchopulmonary dysplasia at 36 weeks of life. Infants were studied in a supine position with the pulse oximeter in position with good signal prior to collecting baseline data. Feedings and medications were given 30 minutes before the evaluation. Baseline data was collected on infant's current oxygen. Then, the infants were weaned to room air for 30 minutes. If saturations remain ≥90%, the infant was considered to have passed the oxygen reduction challenge (to NOT have BPD). The infant should then be placed back in his/her baseline oxygen. If the infant has saturations \<90% for 5 continuous minutes or \<80% for 15 seconds, the infant should be immediately placed back in his/her baseline oxygen, and the infant was considered to have NOT passed the challenge (to have BPD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2005
Typical duration for all trials
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 14, 2010
CompletedFirst Posted
Study publicly available on registry
October 18, 2010
CompletedSeptember 26, 2017
September 1, 2017
3 years
October 14, 2010
September 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bronchopulmonary dysplasia
36 weeks of life
Eligibility Criteria
Premature infants on mechanical ventilation at 36 weeks of life.
You may qualify if:
- Infant with birthweight 401-1500 grams
- Alive at 36+1 week corrected age
- On supplemental oxygen as follows:
- A. Infants receiving oxygen by hood at rest:
- A1. Oxygen by hood \<27% with majority\* of saturations ≥ 90% in prior 24 hours.
- A2. Oxygen by hood 27-30% with majority\* of saturations ≥ 96% in prior 24 hours
- B. Infants receiving oxygen by nasal cannula at restΔ:
- B1. Oxygen by nasal cannula \<27% EFFECTIVE\*\* oxygen and majority\* of saturations ≥90% in prior 24 hours.
- B2. Oxygen by nasal cannula 27-30% EFFECTIVE\*\* oxygen and majority\* saturations ≥96% on prior 24 hours.
- C. Infants receiving room air by nasal cannula at ANY liter per minute (lpm) flow.
You may not qualify if:
- Need for mechanical ventilation or continuous positive airway pressure (CPAP)
- Oxygen by hood \>30%
- Oxygen by nasal cannula \>30% effective oxygen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (21)
University of Alabama
Birmingham, Alabama, 35249-7335, United States
Stanford University
Palo Alto, California, 94304, United States
University of California at San Diego
San Diego, California, 92103-8774, United States
Yale University
New Haven, Connecticut, 06504, United States
University of Miami
Miami, Florida, 33136, United States
Emory University
Atlanta, Georgia, 30303, United States
Indiana University
Indianapolis, Indiana, 46202, United States
University of Iowa
Iowa City, Iowa, 52242, United States
Tufts Medical Center
Boston, Massachusetts, 02111, United States
Wayne State University
Detroit, Michigan, 48201, United States
University of New Mexico
Albuquerque, New Mexico, 87131, United States
University of Rochester
Rochester, New York, 14642, United States
Wake Forest University
Charlotte, North Carolina, 27157, United States
RTI International
Durham, North Carolina, 27705, United States
Duke University
Durham, North Carolina, 27710, United States
Cincinnati Children's Medical Center
Cincinnati, Ohio, 45267, United States
Case Western Reserve University, Rainbow Babies and Children's Hospital
Cleveland, Ohio, 44106, United States
Brown University, Women & Infants Hospital of Rhode Island
Providence, Rhode Island, 02905, United States
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, 75235, United States
University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
University of Utah
Salt Lake City, Utah, 84108, United States
Related Publications (1)
Walsh MC, Yao Q, Gettner P, Hale E, Collins M, Hensman A, Everette R, Peters N, Miller N, Muran G, Auten K, Newman N, Rowan G, Grisby C, Arnell K, Miller L, Ball B, McDavid G; National Institute of Child Health and Human Development Neonatal Research Network. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004 Nov;114(5):1305-11. doi: 10.1542/peds.2004-0204.
PMID: 15520112BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michele C. Walsh, MD MS
Case Western Reserve University, Rainbow Babies & Children's Hospital
- PRINCIPAL INVESTIGATOR
Abbot R. Laptook, MD
Brown University, Women & Infants Hospital of Rhode Island
- PRINCIPAL INVESTIGATOR
Kurt Schibler, MD
Children's Hospital Medical Center, Cincinnati
- PRINCIPAL INVESTIGATOR
Ronald N. Goldberg, MD
Duke University
- PRINCIPAL INVESTIGATOR
Barbara J. Stoll, MD
Emory University
- PRINCIPAL INVESTIGATOR
Brenda B. Poindexter, MD MS
Indiana University
- PRINCIPAL INVESTIGATOR
Krisa P. Van Meurs, MD
Stanford University
- PRINCIPAL INVESTIGATOR
Ivan D. Franz, III, MD
Tufts Medical Center
- PRINCIPAL INVESTIGATOR
Waldemar A. Carlo, MD
University of Alabama at Birmingham
- PRINCIPAL INVESTIGATOR
Neil N. Finer, MD
University of California, San Diego
- PRINCIPAL INVESTIGATOR
Edward F. Bell, MD
University of Iowa
- PRINCIPAL INVESTIGATOR
Charles R. Bauer, MD
University of Miami
- PRINCIPAL INVESTIGATOR
Kristi L. Watterberg, MD
University of New Mexico
- PRINCIPAL INVESTIGATOR
Dale L. Phelps, MD
University of Rochester
- PRINCIPAL INVESTIGATOR
Roger G. Faix, MD
University of Utah
- PRINCIPAL INVESTIGATOR
Pablo J. Sanchez, MD
University of Texas, Southwestern Medical Center at Dallas
- PRINCIPAL INVESTIGATOR
Kathleen A. Kennedy, MD MPH
The University of Texas Health Science Center, Houston
- PRINCIPAL INVESTIGATOR
T. Michael O'Shea, MD MPH
Wake Forest University
- PRINCIPAL INVESTIGATOR
Seetha Shankaran, MD
Wayne State University
- PRINCIPAL INVESTIGATOR
Richard A. Ehrenkranz, MD
Yale University
- PRINCIPAL INVESTIGATOR
Abhik Das, PhD
RTI International
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2010
First Posted
October 18, 2010
Study Start
May 1, 2005
Primary Completion
May 1, 2008
Study Completion
September 1, 2008
Last Updated
September 26, 2017
Record last verified: 2017-09